Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models

From MaRDI portal
Publication:2809552

DOI10.1111/BIOM.12340zbMATH Open1395.62337arXiv1402.3896OpenAlexW2164822863WikidataQ40808409 ScholiaQ40808409MaRDI QIDQ2809552FDOQ2809552

X. Li, Susan J. Simmons, Y. Wang, Q. Fang, C. Chen, W. W. Piegorsch

Publication date: 30 May 2016

Published in: Biometrics (Search for Journal in Brave)

Abstract: An important objective in biomedical risk assessment is estimation of minimum exposure levels that induce a pre-specified adverse response in a target population. The exposure/dose points in such settings are known as Benchmark Doses (BMDs). Recently, parametric Bayesian estimation for finding BMDs has become popular. A large variety of candidate dose-response models is available for applying these methods, however, leading to questions of model adequacy and uncertainty. Here we enhance the Bayesian estimation technique for BMD analysis by applying Bayesian model averaging to produce point estimates and (lower) credible bounds. We include reparameterizations of traditional dose-response models that allow for more-focused use of elicited prior information when building the Bayesian hierarchy. Performance of the method is evaluated via a short simulation study. An example from carcinogenicity testing illustrates the calculations.


Full work available at URL: https://arxiv.org/abs/1402.3896





Cites Work


Cited In (3)

Uses Software






This page was built for publication: Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2809552)